INmune Bio Inc. Announces Third Quarter 2025 Results and Provides Business Update Oct 30, 2025 04:05PM
INmune Bio to Participate in Dermatologic Rare Disease Panel at the Maxim Growth Summit 2025 Oct 14, 2025 07:00AM
INmune Bio (INMB) Prices 986K Share Offering at $9.84/sh Apr 25, 2024 09:01AM
INmune Bio Inc. Announces $9.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules Apr 25, 2024 09:00AM
INmune Bio, Inc. to Participate in the 32nd Annual Oppenheimer Healthcare Conference and the 2022 Maxim Group Virtual Growth Conference Mar 14, 2022 04:30PM


Mar 14, 2022 04:30PM INmune Bio, Inc. to Participate in the 32nd Annual Oppenheimer Healthcare Conference and the 2022 Maxim Group Virtual Growth Conference
May 24, 2021 09:00AM INmune Bio, Inc. to Participate in Alzheimer Disease Panel Presented by Maxim Group LLC and hosted by M-Vest on May 26th, 2021
May 24, 2021 09:00AM INmune Bio, Inc. to Participate in Alzheimer Disease Panel Presented by Maxim Group LLC and hosted by M-Vest on May 26th, 2021
Apr 28, 2020 09:00AM INmune Bio, Inc. to Speak on COVID-19 Therapeutic Panel at Maxim Group’s Infectious Disease Virtual Conference on May 5, 2020
Apr 28, 2020 09:00AM INmune Bio, Inc. to Speak on COVID-19 Therapeutic Panel at Maxim Group’s Infectious Disease Virtual Conference on May 5, 2020
Jul 3, 2019 12:09PM NetworkNewsBreaks – INmune Bio Inc. (NASDAQ: INMB) Co-Founder and CEO Showcases XPro1595 at Maxim Group’s Conference on Alzheimer’s Disease
Jul 3, 2019 09:01AM INmune Bio Co-Founder and CEO Presents at Maxim Group’s Conference on Alzheimer’s Disease
Mar 19, 2019 07:34AM Maxim Group Starts INmune Bio Inc. (INMB) at Buy